All Diclofenac articles

Article

Akorn to pay $7.9M for Medicare false claims

2022-09-15T18:31:00Z

Drug manufacturer Akorn Operating Company agreed to pay $7.9 million in a settlement with the Department of Justice for continuing to sell three drugs through Medicare when they were no longer covered under the program.